Conserved T cell receptor α-chain induces insulin autoantibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 29, 2008, Pages 10090-10094

  Kobayashi, Masakazu ^a   Jasinski, Jean ^a   Liu, Edwin ^a   Li, Marcella ^a   Miao, Dongmei ^a   Zhang, Li ^a   Yu, Liping ^a   Nakayama, Maki ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoimmunity; NOD mouse; Retrogenic; Type 1 diabetes

Indexed keywords

INSULIN ANTIBODY; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL CLONE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; BASE SEQUENCE; CLONE CELLS; CONSERVED SEQUENCE; DNA PRIMERS; FEMALE; GENES, T-CELL RECEPTOR ALPHA; GENES, T-CELL RECEPTOR BETA; INSULIN; INSULIN ANTIBODIES; INTERFERON TYPE II; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

MUS;

EID: 48249109500     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801648105     Document Type: Article

References (30)

1. Lieberman SM, DiLorenzo TP (2003) A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62:359-377.
2. Thebault-Baumont K, et al. (2003) Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 111:851-857.
3. Nakayama M, et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220-223.
4. Moriyama H, et al. (2003) Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci USA 100:10376-10381.
5. Jaeckel E, Lipes MA, von Boehmer H (2004) Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 5:1028-1035.
6. Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H (2003) Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med 197:1635-1644.
7. Kubosaki A, Miura J, Notkins AL (2004) IA-2 is not required for the development of diabetes in NOD mice. Diabetologia 47:149-150.
8. Kubosaki A, et al. (2004) Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice. Diabetes 53:1684-1691.
9. Krishnamurthy B, et al. (2006) Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116:3258-3265.
10. Daniel D, Gill RG, Schloot N, Wegmann D (1995) Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062.
11. Jasinski JM, et al. (2006) Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55:1978-1984.
12. Du W, et al. (2006) TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 116:1360-1370.
13. Wong FS, et al. (1999) Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 5:1026-1031.
14. Simone EA, Yu L, Wegmann DR, Eisenbarth GS (1997) T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice. J Autoimmun 10:317-321.
15. Simone E, et al. (1997) T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 94:2518-2521.
16. Homann D, Eisenbarth GS (2006) An immunologic homunculus for type 1 diabetes. J Clin Invest 116:1212-1215.
17. Abiru N, et al. (2001) Peptide and MHC specific breaking of humoral tolerance to native insulin with the B:9-23 peptide in diabetes prone and normal mice. Diabetes 50:1274-1281.
18. Abiru N et al. (2001) Transient insulin autoantibody expression independent of development of diabetes: Comparison of NOD and NOR strains. J Autoimmun 17:1-6.
19. Liu E, Abiru N, Moriyama H, Miao D, Eisenbarth GS (2002) Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant. Ann N Y Acad Sci 958:224-227.
20. Abiru N, et al. (2000) Dual overlapping peptides recognized by insulin peptide B:9-23 reactive T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun 14:231-237.
21. Kent SC, et al. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435:224-228.
22. Gianani R, et al. (2006) Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 91:1855-1861.
23. Nakayama M, et al. (2007) Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 117:1835-1843.
24. Mukherjee R, Chaturvedi P, Qin HY, Singh B (2003) CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J Autoimmun 21:221-237.
25. Davis MM, Bjorkman PJ (1988) T cell antigen receptor genes and T cell recognition. Nature 334:395-402.
26. Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180:1097-1106.
27. MacDonald HR (2007) NKT cells: In the beginning. Eur J Immunol 37(Suppl. 1):111-115.
28. Chatila TA (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949-959.
29. Holst J et al. (2006) Generation of T-cell receptor retrogenic mice. Nat Protoc 1:406-417.
30. Yu L, et al. (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701-1706.